These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 14024037)
1. Clinical trial of delautin in the treatment of advanced mammary carcinoma in postmenopausal women. CROWLEY LG; MACDONALD I Cancer; 1962; 15():1218-20. PubMed ID: 14024037 [No Abstract] [Full Text] [Related]
2. DELALUTIN AND ESTROGENS FOR THE TREATMENT OF ADVANCED MAMMARY CARCINOMA IN THE POSTMENOPAUSAL WOMAN. CROWLEY LG; MACDONALD I Cancer; 1965 Apr; 18():436-46. PubMed ID: 14278040 [No Abstract] [Full Text] [Related]
4. THE INFLUENCE OF GESTAGENS ON THE URINARY EXCRETION OF PITUITARY GONADOTROPINS, ESTROGENS, AND PREGNANEDIOL IN WOMEN IN THE POSTMENOPAUSE AND DURING THE MENSTRUAL CYCLE. BUCHHOLZ R; NOCKE L; NOCKE W Int J Fertil; 1964; 9():231-51. PubMed ID: 14106262 [No Abstract] [Full Text] [Related]
5. Adult weight change and risk of postmenopausal breast cancer. Eliassen AH; Colditz GA; Rosner B; Willett WC; Hankinson SE JAMA; 2006 Jul; 296(2):193-201. PubMed ID: 16835425 [TBL] [Abstract][Full Text] [Related]
6. [MAMMARY DYSPLASIAS: MEDICAL TREATMENT]. PASI PL Rev Asoc Med Argent; 1964 Mar; 78():120-3. PubMed ID: 14150264 [No Abstract] [Full Text] [Related]
7. Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. Kabat GC; Kim MY; Woods NF; Habel LA; Messina CR; Wactawski-Wende J; Stefanick ML; Chlebowski RT; Wassertheil-Smoller S; Rohan TE Cancer Causes Control; 2011 Oct; 22(10):1415-24. PubMed ID: 21750889 [TBL] [Abstract][Full Text] [Related]
8. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study. Harvie M; Howell A; Vierkant RA; Kumar N; Cerhan JR; Kelemen LE; Folsom AR; Sellers TA Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):656-61. PubMed ID: 15767346 [TBL] [Abstract][Full Text] [Related]
9. Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers. Brown KA; Iyengar NM; Zhou XK; Gucalp A; Subbaramaiah K; Wang H; Giri DD; Morrow M; Falcone DJ; Wendel NK; Winston LA; Pollak M; Dierickx A; Hudis CA; Dannenberg AJ J Clin Endocrinol Metab; 2017 May; 102(5):1692-1701. PubMed ID: 28323914 [TBL] [Abstract][Full Text] [Related]
10. Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma. Samojlik E; Santen RJ J Clin Endocrinol Metab; 1978 Oct; 47(4):717-24. PubMed ID: 162517 [TBL] [Abstract][Full Text] [Related]
11. Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer. Harris AL; Dowsett M; Smith IE; Jeffcoate SL Br J Cancer; 1983 May; 47(5):621-7. PubMed ID: 6221746 [TBL] [Abstract][Full Text] [Related]
12. [Description of some cases of mammary and uterine carcinoma treated with hydroxyprogesterone capronate]. Barnaba T Minerva Ginecol; 1970 Oct; 22(19):957-63. PubMed ID: 5515156 [No Abstract] [Full Text] [Related]
13. Dietary Associations with a Breast Cancer Risk Biomarker Depend on Menopause Status. Hidaka BH; Carlson SE; Kimler BF; Fabian CJ Nutr Cancer; 2016 Oct; 68(7):1115-22. PubMed ID: 27618149 [TBL] [Abstract][Full Text] [Related]
14. High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer. Harris AL; Cantwell BM; Dowsett M Br J Cancer; 1988 Oct; 58(4):493-6. PubMed ID: 2974717 [TBL] [Abstract][Full Text] [Related]
15. A mouse model to study the effects of hormone replacement therapy on normal mammary gland during menopause: enhanced proliferative response to estrogen in late postmenopausal mice. Raafat AM; Hofseth LJ; Li S; Bennett JM; Haslam SZ Endocrinology; 1999 Jun; 140(6):2570-80. PubMed ID: 10342844 [TBL] [Abstract][Full Text] [Related]
16. Effect of long-term treatment with raloxifene on mammary density in postmenopausal women. Lasco A; Gaudio A; Morini E; Morabito N; Nicita-Mauro C; Catalano A; Denuzzo G; Sansotta C; Xourafa A; Macrì I; Frisina N Menopause; 2006; 13(5):787-92. PubMed ID: 16912660 [TBL] [Abstract][Full Text] [Related]
17. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause]. Cao YK; Zhang SF; Zou SE; Xia X; Xu LN Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129 [TBL] [Abstract][Full Text] [Related]
18. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer]. Novoa Vargas A; Font López KC; Amador DD Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856 [TBL] [Abstract][Full Text] [Related]
19. Effects of soy isoflavones on mammographic density and breast parenchyma in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial. Delmanto A; Nahas-Neto J; Traiman P; Uemura G; Pessoa EC; Nahas EA Menopause; 2013 Oct; 20(10):1049-54. PubMed ID: 23481125 [TBL] [Abstract][Full Text] [Related]
20. The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy. Genazzani AR; Schneider HP; Panay N; Nijland EA Gynecol Endocrinol; 2006 Jul; 22(7):369-75. PubMed ID: 16864146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]